InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
5
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-14.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Thornton Michael Milos, Chief Technology Officer. Insider active across 1 company, notably ENDRA Life Sciences Inc.. Aggregated, 7 reports have been published. Split: 5 buys · 0 sell. Total volume traded: €43k. Activity tracked since 28 January 2021. The latest transaction was filed on 18 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
15,000 shares@ US$1.6553.0% of flowCommon StockSEC:0001209191-23-031298:0
Ideal exit: 12 Feb 2024 (T+270)
1,500 shares@ US$3.4011.1% of flowCommon StockSEC:0001209191-22-060895:0
Ideal exit: 5 Sept 2023 (T+270)
20,000 shares@ US$0.2712.5% of flowCommon StockSEC:0001209191-22-047298:0
Ideal exit: 19 May 2023 (T+270)
25,000 shares@ US$0.210.078% mcap48.2% of flowCommon StockSEC:0001209191-22-032746:0
Ideal exit: 20 Feb 2023 (T+270)
25,000 shares@ US$0.220.084% mcap51.8% of flowCommon StockSEC:0001209191-22-031319:0
Ideal exit: 12 Feb 2023 (T+270)
22,815 shares0Common StockSEC:0001209191-21-057234:0
22,815 shares0Common StockSEC:0001209191-21-057234
7 of 7 declarations
About Thornton Michael Milos
Michael Milos Thornton is the Chief Technology Officer at ENDRA Life Sciences Inc. He is responsible for the technical direction of the company, overseeing the development of new technologies and innovation. His technical expertise is crucial for the company's success in the life sciences sector, contributing to the improvement of healthcare solutions.
